Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias

Leukemia Research

Volumn 38, Issue 12, 2014, Pages 1413-1419

  Schuler, E ^a   Schroeder, M ^a   Neukirchen, J ^a   Strupp, C ^a   Xicoy, B ^a   Kundgen A ^a   Hildebrandt, B ^a   Haas, R ^a   Gattermann, N ^a   Germing, U ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

CMML; CPSS; MDS; MDS MPN; Overlap; Prognosis

Indexed keywords

HEMOGLOBIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CHRONIC MYELOMONOCYTIC LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA PROGNOSTIC SCORING SYSTEM; DUESSELDORF SCORE; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDULLARY BLAST COUNT; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; SCORING SYSTEM; SURVIVAL TIME; THROMBOCYTE COUNT; BLAST CELL CRISIS; BLOOD; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLASSIFICATION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL RATE;

BLAST CRISIS; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKOCYTE COUNT; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84915750567     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2014.09.003     Document Type: Article

References (19)

1. Brunning R.D., Orazi A., Germing U., Le Beau M.M., Porwit A., Bauman I., et al. Myelodysplastic, syndromes. WHO classification of tumours of haematopoetic and lymphoid tissues 2008, IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
2. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982, 51(June (2)):189-199.
3. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H., et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994, 87(August (4)):746-754.
4. Germing U., Gattermann N., Minning H., Heyll A., Aul C. Problems in the classification of CMML - dysplastic versus proliferative type. Leuk Res 1998, 22(October (10)):871-878.
5. Fenaux P., Morel P., Lai J.L. Cytogenetics of myelodysplastic syndromes. Semin Hematol 1996, 33(April (2)):127-138.
6. Such E., Cervera J., Costa D., Sole F., Vallespi T., Luno E., et al. Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica 2011, 96(March (3)):375-383.
7. Abdel-Wahab O., Mullally A., Hedvat C., Garcia-Manero G., Patel J., Wadleigh M., et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 2009, 114(July (1)):144-147.
8. Kohlmann A., Grossmann V., Klein H.U., Schindela S., Weiss T., Kazak B., et al. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010, 28(August (24)):3858-3865.
9. Meggendorfer M., Roller A., Haferlach T., Eder C., Dicker F., Grossmann V., et al. SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood 2012, 120(October (15)):3080-3088.
10. Itzykson R., Kosmider O., Renneville A., Gelsi-Boyer V., Meggendorfer M., Morabito M., et al. Prognostic score including gene mutations in chronic myelomonocytic leukemia. J Clin Oncol 2013, 31(July (19)):2428-2436.
11. Kosmider O., Gelsi-Boyer V., Ciudad M., Racoeur C., Jooste V., Vey N., et al. TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia. Haematologica 2009, 94(December (12)):1676-1681.
12. Onida F., Kantarjian H.M., Smith T.L., Ball G., Keating M.J., Estey E.H., et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002, 99(Februar (3)):840-849.
13. Aul C., Gattermann N., Heyll A., Germing U., Derigs G., Schneider W. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 1992, 6(January (1)):52-59.
14. Worsley A., Oscier D.G., Stevens J., Darlow S., Figes A., Mufti G.J., et al. Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. Br J Haematol 1988, 68(January (1)):17-21.
15. Gonzalez-Medina I., Bueno J., Torrequebrada A., Lopez A., Vallespi T., Massague I. Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloproliferative Prognostic implications in a series of a single center. Leuk Res 2002, 9(September):821-824.
16. Such E., Germing U., Malcovati L., Cervera J., Kuendgen A., Della Porta M.G., et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood 2013, 121(April (15)):3005-3015.
17. Germing U., Strupp C., Kundgen A., Bowen D., Aul C., Haas R., et al. No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 2004, 89(August (8)):905-910.
18. Germing U., Strupp C., Kuendgen A., Isa S., Knipp S., Hildebrandt B., et al. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica 2006, 91(December (12)):1596-1604.
19. Sanz G.F., Sanz M.A., Vallespi T., Canizo M.C., Torrabadella M., Garcia S., et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989, 74(July (1)):395-408.